المؤلفون: Zumla A; Center for Clinical Microbiology, Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK. Electronic address: a.i.zumla@gmail.com., Schito M; Critical Path to TB Drug Regimens, Critical Path Institute, Tucson, AZ, USA., Chakaya J; Kenya Medical Research Institute, Nairobi, Kenya., Marais B; The Children's Hospital at Westmead, Sydney Medical School, University of Sydney, Sydney, NSW, Australia., Mwaba P; Ministry of Health, Lusaka, Zambia., Migliori GB; WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S Maugeri, Care and Research Institute, Tradate, Italy., Hoelscher M; Division of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich, and DZIF German Centre for Infection Research, Munich, Germany., Maeurer M; Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, and Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden., Wallis RS; Aurum Institute, Johannesburg, South Africa.

المصدر: The Lancet. Respiratory medicine [Lancet Respir Med] 2016 Apr; Vol. 4 (4), pp. 249-51. Date of Electronic Publication: 2016 Mar 23.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2619 (Electronic) Linking ISSN: 22132600 NLM ISO Abbreviation: Lancet Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: Global Health*, Tuberculosis/*diagnosis , Tuberculosis/*therapy, Antitubercular Agents/therapeutic use ; Emergencies ; Humans ; World Health Organization

المؤلفون: Kaufmann SH; Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany., Lange C; Division of Clinical Infectious Diseases, Medical Clinic, Research Center Borstel, German Center for Infection Research (DZIF), Borstel, Germany., Rao M; Center for Allogeneic Stem Cell Transplantation (CAST), Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Balaji KN; Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, Karnataka, India., Lotze M; University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA; University of Pittsburgh Schools of the Health Sciences, Hillman Cancer Center, Pittsburgh, PA, USA., Schito M; Henry M Jackson Foundation-Division of AIDS, TB Clinical Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Zumla AI; Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, London, UK; UCL Hospitals NHS Foundation Trust, London, UK., Maeurer M; Center for Allogeneic Stem Cell Transplantation (CAST), Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: Markus.Maeurer@ki.se.

المصدر: The Lancet. Respiratory medicine [Lancet Respir Med] 2014 Apr; Vol. 2 (4), pp. 301-20. Date of Electronic Publication: 2014 Mar 24.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2619 (Electronic) Linking ISSN: 22132600 NLM ISO Abbreviation: Lancet Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents* , Biomedical Research* , Mycobacterium tuberculosis*/drug effects , Mycobacterium tuberculosis*/immunology , Tuberculosis Vaccines*, Tuberculosis/*drug therapy, Humans ; Tuberculosis/immunology ; Tuberculosis/prevention & control

المؤلفون: Maeurer M; Therapeutic Immunology Division, Department of Laboratory Medicine, Karolinska Institutet, Hälsövägen F79, Huddinge, SE-14186 Stockholm, Sweden; Center for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden. Electronic address: markus.maeurer@ki.se., Schito M; Henry M Jackson Foundation-Division of AIDS, Tuberculosis Clinical Research Branch, National Institute of Allergy and infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Zumla A; Division of Infection and Immunity, University College London, London, UK; Department of Medical Microbiology, University College London Hospitals NHS Trust, London, UK.

المصدر: The Lancet. Respiratory medicine [Lancet Respir Med] 2014 Apr; Vol. 2 (4), pp. 256-7. Date of Electronic Publication: 2014 Mar 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2619 (Electronic) Linking ISSN: 22132600 NLM ISO Abbreviation: Lancet Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: Extensively Drug-Resistant Tuberculosis/*drug therapy , Mycobacterium/*pathogenicity, Extensively Drug-Resistant Tuberculosis/immunology ; Extensively Drug-Resistant Tuberculosis/microbiology ; Humans ; Mycobacterium/immunology